38:
238:
421:
48:
An Act to amend the
Federal Food, Drug, and Cosmetic Act to ban the reimportation of drugs produced in the United States, to place restrictions on the distribution of drug samples, to ban certain resales of drugs by hospitals and other health care facilities, and for other
497:
620:
490:
610:
483:
436:
268:
469:
283:
600:
313:
585:
615:
464:
263:
441:
323:
115:
135:
125:
538:. It was passed in response to the development of a wholesale sub-market (known as the "diversion market") for prescription drugs.
519:
393:
171:
605:
573:
328:
96:
88:
219:
557:
545:
459:
318:
58:
383:
376:
541:
The PDMA was modified by the
Prescription Drug Amendments of 1992 (P.L. 102-353, 106 Stat. 941) on August 26, 1992.
431:
426:
295:
273:
37:
366:
548:(FDA) issued regulations implementing the PDMA in 1990 (21 C.F.R. Part 205) and 1999 (21 C.F.R. Part 203).
288:
249:
17:
361:
81:
568:
163:
563:
523:
388:
245:
398:
356:
148:
237:
527:
371:
346:
139:
594:
403:
203:
167:
531:
351:
175:
100:
535:
534:, adulterated, misbranded, sub potent, and expired prescription
621:
United States statutes that abrogate
Supreme Court decisions
611:
United States federal controlled substances legislation
518:) of 1987 (P.L. 100-293, 102 Stat. 95) is a law of the
231:
Regulation of therapeutic goods in the United States
213:
146:
131:
121:
111:
106:
87:
77:
72:
64:
53:
44:
491:
8:
601:Pharmaceutical industry in the United States
30:
530:and is designed to discourage the sale of
526:distribution to ensure safe and effective
498:
484:
236:
227:
196:on March 31, 1988 (passed voice vote)
184:by House Committee on Energy and Commerce
616:United States federal health legislation
522:. It establishes legal safeguards for
314:Department of Health and Human Services
230:
190:on May 4, 1987 (passed voice vote)
31:Prescription Drug Marketing Act of 1987
29:
18:Prescription Drug Marketing Act (PDMA)
7:
264:Federal Food, Drug, and Cosmetic Act
220:Prescription Drug Amendments of 1992
442:Single Convention on Narcotic Drugs
116:Federal Food, Drug and Cosmetic Act
25:
520:United States federal government
394:Abbreviated New Drug Application
36:
27:Legislation in the United States
574:Regulation of therapeutic goods
512:Prescription Drug Marketing Act
279:Prescription Drug Marketing Act
454:Non-governmental organizations
1:
558:Food and Drug Administration
546:Food and Drug Administration
460:National Academy of Medicine
319:Food and Drug Administration
59:100th United States Congress
384:Randomized controlled trial
222:P.L. 102-353, 106 Stat. 941
637:
416:International coordination
427:Uppsala Monitoring Centre
296:Marihuana Tax Act of 1937
274:Controlled Substances Act
218:
155:
126:21 U.S.C.: Food and Drugs
35:
367:Investigational New Drug
182:Committee consideration
132:U.S.C. sections amended
606:Pharmaceuticals policy
250:Over-the-counter drugs
178:) on February 24, 1987
324:Department of Justice
362:New Drug Application
569:Inverse benefit law
399:Fast track approval
308:Government agencies
149:Legislative history
32:
246:Prescription drugs
564:Drug distribution
524:prescription drug
508:
507:
389:Pharmacovigilance
226:
225:
206:on April 22, 1988
194:Passed the Senate
90:Statutes at Large
16:(Redirected from
628:
500:
493:
486:
357:Drug development
284:Hatch-Waxman Act
240:
228:
214:Major amendments
188:Passed the House
162:in the House as
151:
142:§§ 331, 353, 381
91:
40:
33:
21:
636:
635:
631:
630:
629:
627:
626:
625:
591:
590:
582:
554:
528:pharmaceuticals
504:
475:
474:
455:
447:
446:
417:
409:
408:
342:
334:
333:
309:
301:
300:
259:
248:
209:
200:Signed into law
147:
89:
54:Enacted by
28:
23:
22:
15:
12:
11:
5:
634:
632:
624:
623:
618:
613:
608:
603:
593:
592:
589:
588:
581:
580:External links
578:
577:
576:
571:
566:
561:
553:
550:
506:
505:
503:
502:
495:
488:
480:
477:
476:
473:
472:
467:
462:
456:
453:
452:
449:
448:
445:
444:
439:
434:
429:
424:
418:
415:
414:
411:
410:
407:
406:
401:
396:
391:
386:
381:
380:
379:
372:Clinical trial
369:
364:
359:
354:
349:
347:Drug discovery
343:
340:
339:
336:
335:
332:
331:
326:
321:
316:
310:
307:
306:
303:
302:
299:
298:
293:
292:
291:
281:
276:
271:
266:
260:
257:
256:
253:
252:
242:
241:
233:
232:
224:
223:
216:
215:
211:
210:
208:
207:
197:
191:
185:
179:
164:H.R. 1207
156:
153:
152:
144:
143:
133:
129:
128:
123:
122:Titles amended
119:
118:
113:
109:
108:
104:
103:
93:
85:
84:
79:
75:
74:
70:
69:
68:April 22, 1988
66:
62:
61:
55:
51:
50:
46:
42:
41:
26:
24:
14:
13:
10:
9:
6:
4:
3:
2:
633:
622:
619:
617:
614:
612:
609:
607:
604:
602:
599:
598:
596:
587:
584:
583:
579:
575:
572:
570:
567:
565:
562:
559:
556:
555:
551:
549:
547:
542:
539:
537:
533:
529:
525:
521:
517:
513:
501:
496:
494:
489:
487:
482:
481:
479:
478:
471:
468:
466:
463:
461:
458:
457:
451:
450:
443:
440:
438:
435:
433:
430:
428:
425:
423:
420:
419:
413:
412:
405:
404:Off-label use
402:
400:
397:
395:
392:
390:
387:
385:
382:
378:
375:
374:
373:
370:
368:
365:
363:
360:
358:
355:
353:
350:
348:
345:
344:
338:
337:
330:
327:
325:
322:
320:
317:
315:
312:
311:
305:
304:
297:
294:
290:
287:
286:
285:
282:
280:
277:
275:
272:
270:
267:
265:
262:
261:
255:
254:
251:
247:
244:
243:
239:
235:
234:
229:
221:
217:
212:
205:
204:Ronald Reagan
202:by President
201:
198:
195:
192:
189:
186:
183:
180:
177:
173:
169:
165:
161:
158:
157:
154:
150:
145:
141:
137:
134:
130:
127:
124:
120:
117:
114:
110:
105:
102:
98:
94:
92:
86:
83:
80:
76:
71:
67:
63:
60:
56:
52:
47:
43:
39:
34:
19:
586:PDMA article
543:
540:
515:
511:
509:
278:
199:
193:
187:
181:
168:John Dingell
159:
112:Acts amended
107:Codification
532:counterfeit
352:Drug design
595:Categories
560:(FDA, USA)
289:exemptions
160:Introduced
78:Public law
45:Long title
544:The U.S.
136:21 U.S.C.
95:102
73:Citations
65:Effective
49:purposes.
552:See also
341:Process
82:100-293
377:phases
269:CDAPCA
99:
536:drugs
470:NORML
465:RADAR
437:CIOMS
140:ch. 9
138:
97:Stat.
516:PDMA
510:The
57:the
432:WHO
422:ICH
329:DEA
258:Law
166:by
597::
176:MI
101:95
514:(
499:e
492:t
485:v
174:–
172:D
170:(
20:)
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.
